Anika Therapeutics (ANIK) Tops Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $15.36 +1.19%
EPS Growth %: +115.4%
Financial Fact:
Selling, general & administrative: 4.28M
Today's EPS Names:
CRMT, More
EPS Growth %: +115.4%
Financial Fact:
Selling, general & administrative: 4.28M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of ($0.11), $0.13 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $37.9 million versus the consensus estimate of $38.95 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Goldman's Garrett sees investors dialing back tech exposure into H2
- RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
